MORPHEAFORM BASAL CELL CARCINOMA

By Gary M. White, MD

Morpheaform Basal Cell Carcinoma The morpheaform BCC may take on a yellowish hue as shown here.


A morpheaform basal cell carcinoma is a BCC which histologically has a fibrotic or scar-like component. It is often more aggressive than the nodular BCC. The prior use of fluorouracil has been shown to predispose to the development of morpheaform BCC in elderly men with an OR of 2.49 [JAMADerm 2014;150;332]. Also patients whose first BCC was morpheaform and that developed a second BCC, the second BCC was 12 times more likely to be morpheaform compared with patients whose first BCC was not morpheaform.

Clinical

The morpheaform BCC resembles the more common nodular BCC in many ways, although it may have a slightly more yellowish tinge.

Treatment

Surgical excision is the indicated treatment. Mohs surgery is appropriate for lesions on the face. Therapies used for other histologic types of BCC, e.g. photodynamic therapy are not sufficiently effective for morpheaform BCC.

Additional Pictures

The histology may not be readily apparent clinically. This BCC had a morpheaform histology on biopsy.
Morpheaform Basal Cell Carcinoma

RegionalDerm

Homepage | FAQs | Use of Images | Contact Dr. White


It is not the intention of RegionalDerm.com to provide specific medical advice, diagnosis or treatment. RegionalDerm.com only intends to provide users with information regarding various medical conditions for educational purposes and will not provide specific medical advice. Information on RegionalDerm.com is not intended as a substitute for seeking medical treatment and you should always seek the advice of a qualified healthcare provider for diagnosis and for answers to your individual questions. Information contained on RegionalDerm.com should never cause you to disregard professional medical advice or delay seeking treatment. If you live in the United States and believe you are having a medical emergency call 911 immediately.